PSIQI

Investor overview · November 2026

The case for
measured growth.

Acquire a sound laboratory business. Strengthen the operating foundation. Expand where the evidence supports it.

Current stage: pre-acquisition

The thesis at a glance

An operating asset.
A disciplined path
to greater value.

Entry point
An established analytical laboratory, initially focused on Colorado.
Target profile
$500k–$3m proposed annual target revenue. A screening range, not PSIQI revenue or a valuation.
Value creation
Customer continuity, method quality, useful documentation and reliable service.
Expansion
Specialized services and future research capabilities, each with its own investment decision.

Business model

Build on what
customers already need.

Underwrite the foundation first.
Validate each new revenue stream.

Initial focus

Existing
laboratory services

Retain acquired accounts and improve delivery in the target's established service lines.

Evidence: retained customers and actual cash flow
Potential expansion

Methods
& stability

Evaluate focused scientific projects with clear buyer needs, qualified methods and supportable pricing.

Evidence: customer demand and delivery economics
Long-term option

Research
& API development

Consider controlled research and manufacturing pathways only with the required capability and authorizations.

Evidence: legal scope, quality readiness and funding

Acquisition discipline

The quality of the foundation
sets the quality of the future.

People worth retaining

Scientific and quality leadership, accountable responsibilities and continuity through an ownership change.

Demand that repeats

Recurring customer work, clear service economics and a manageable concentration of revenue.

Records that stand up

Traceable data, credible methods, maintenance history and a clear picture of remediation needs.

A workable transition

Suitable facilities, permissions, contracts and a financing plan supported by diligence.

Proposed first 180 days

Milestones that
reduce uncertainty.

Planning windows from kickoff.
Completion depends on evidence.

  1. Days 1–30

    Define the acquisition screen.

    Establish criteria, counsel scope and the customer interview program.

  2. Days 31–60

    Compare targets and customer needs.

    Build a qualified shortlist and a documented view of demand.

  3. Days 61–90

    Underwrite a specific opportunity.

    Complete financial, scientific and legal diligence with a costed integration plan.

  4. Days 91–180

    Make the investment decision.

    Proceed only when financing, retention and operating permissions support the transaction.

A clear view of the stage

Ambition, with
the assumptions visible.

PSIQI is developing the thesis. The next value inflection is a well-supported acquisition decision.

Developed

Brand, acquisition thesis, operating sequence, current research and investor materials.

To establish

Target, financials, team appointments, financing terms and the applicable operating permissions.

Principal risks

Acquisition execution, customer retention, data integrity, regulatory fit, competition and capital requirements.

No closed acquisition, operating revenue, registration, accreditation, GMP capability or funding commitment has been verified for PSIQI. This is a business overview, not an offer of securities.

Build the foundation with us

Good science starts
with a conversation.

For investors, laboratory owners and scientific partners.

info@psiqi.com